Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers.
Saved in:
| Title: | Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. |
|---|---|
| Authors: | Goglia AG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alshalalfa M; Department of Radiation Oncology, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Khan A; The Miller School of Medicine, University of Miami, Miami, FL, USA., Isakov DR; Human Oncology and Pathogenesis Program, Department of Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hougen HY; Department of Urology, University of Iowa, Iowa City, IA, USA., Swami N; Division of Internal Medicine, University of Pennsylvania Health System, Pennsylvania, PA, USA., Kannikal J; The Miller School of Medicine, University of Miami, Miami, FL, USA., Mcbride SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gomez DR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Punnen S; Desai and Sethi Institute of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA., Nguyen PL; Department of Radiation Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Iyengar P; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Antonarakis ES; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Mahal BA; Department of Radiation Oncology, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Jan 01; Vol. 117 (1), pp. 188-197. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39254651 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goglia+AG%22">Goglia AG</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Alshalalfa+M%22">Alshalalfa M</searchLink>; Department of Radiation Oncology, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Khan+A%22">Khan A</searchLink>; The Miller School of Medicine, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Isakov+DR%22">Isakov DR</searchLink>; Human Oncology and Pathogenesis Program, Department of Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hougen+HY%22">Hougen HY</searchLink>; Department of Urology, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Swami+N%22">Swami N</searchLink>; Division of Internal Medicine, University of Pennsylvania Health System, Pennsylvania, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kannikal+J%22">Kannikal J</searchLink>; The Miller School of Medicine, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Mcbride+SM%22">Mcbride SM</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gomez+DR%22">Gomez DR</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Punnen+S%22">Punnen S</searchLink>; Desai and Sethi Institute of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+PL%22">Nguyen PL</searchLink>; Department of Radiation Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Iyengar+P%22">Iyengar P</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Mahal+BA%22">Mahal BA</searchLink>; Department of Radiation Oncology, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Dee+EC%22">Dee EC</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2025 Jan 01; Vol. 117 (1), pp. 188-197. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39254651 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jnci/djae224 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 188 Titles: – TitleFull: Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goglia AG – PersonEntity: Name: NameFull: Alshalalfa M – PersonEntity: Name: NameFull: Khan A – PersonEntity: Name: NameFull: Isakov DR – PersonEntity: Name: NameFull: Hougen HY – PersonEntity: Name: NameFull: Swami N – PersonEntity: Name: NameFull: Kannikal J – PersonEntity: Name: NameFull: Mcbride SM – PersonEntity: Name: NameFull: Gomez DR – PersonEntity: Name: NameFull: Punnen S – PersonEntity: Name: NameFull: Nguyen PL – PersonEntity: Name: NameFull: Iyengar P – PersonEntity: Name: NameFull: Antonarakis ES – PersonEntity: Name: NameFull: Mahal BA – PersonEntity: Name: NameFull: Dee EC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1460-2105 Numbering: – Type: volume Value: 117 – Type: issue Value: 1 Titles: – TitleFull: Journal of the National Cancer Institute Type: main |
| ResultId | 1 |